Tianyu Corporation: Wholly-owned subsidiary's active pharmaceutical ingredient obtains CEP certificate.

Tianyu Co., Ltd. announced on the evening of July 28th that its wholly-owned subsidiary Zhejiang Jingsheng Pharmaceutical Co., Ltd. has received the European Pharmacopoeia suitability certificate for the active ingredient of Sitagliptin phosphate issued by the European Medicines Agency. Sitagliptin phosphate is a type of antidiabetic drug that can help control blood sugar levels and is mainly used for treating type 2 diabetes.